Antibody removal before ABO-incompatible renal transplantation: How much plasma exchange is therapeutic?

Transplantation

Volumn 92, Issue 10, 2011, Pages 1129-1133

  Lawrence, Christopher ^a   Galliford, Jack W ^a   Willicombe, Michelle K ^a   McLean, Adam G ^a   Lesabe, Mary ^a   Rowan, Fiona ^a   Papalois, Vassilios ^a   Regan, Fiona ^a,b   Taube, David ^a  

^a HAMMERSMITH HOSPITAL   (United Kingdom)

^b NHS BLOOD AND TRANSPLANT   (United Kingdom)

Author keywords

ABO incompatible; Kidney transplantation; Plasma exchange

Indexed keywords

ALEMTUZUMAB; CREATININE; DACLIZUMAB; IMMUNOGLOBULIN; IMMUNOGLOBULIN G ANTIBODY; METHYLPREDNISOLONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISONE; RITUXIMAB; TACROLIMUS;

ADULT; AGED; ANTIBODY TITER; ARTICLE; BLOOD GROUP ABO INCOMPATIBILITY; CREATININE BLOOD LEVEL; DRUG DOSE REDUCTION; DRUG DOSE TITRATION; FEMALE; GRAFT SURVIVAL; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; PLASMAPHERESIS; PRIORITY JOURNAL;

ABO BLOOD-GROUP SYSTEM; ADULT; BLOOD GROUP INCOMPATIBILITY; FEMALE; GRAFT REJECTION; GRAFT SURVIVAL; HUMANS; ISOANTIBODIES; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; PLASMA EXCHANGE; TRANSPLANTATION, HOMOLOGOUS;

EID: 80855123590     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/TP.0b013e31823360cf     Document Type: Article

References (29)

1. Schold J, Srinivas TR, Sehgal AR, et al. Half of kidney transplant candidates who are older than 60 years now placed on the waiting list will die before receiving a deceased-donor transplant. Clin JAmSoc Nephrol 2009; 4: 1239.
2. UKTransplant. Transplant activity in the United Kingdom 2009-2009, p 7.
3. Segev DL, Gentry DL, Warren DS, et al. Kidney paired donation and optimizing the use of live donor organs. JAMA 2005; 293: 1883.
4. Montgomery RA. Renal transplantation across HLA and ABO antibody barriers: Integrating paired donation into desensitization protocols. Am J Trans 2010; 10: 449.
5. HHS/HRSA/HSB/DOT. 2009 OPTN/SRTR Annual report 1999-2008. N2009. Rockville, MD.
6. Merion RM, Ashby VB, Wolfe RA, et al. Deceased donor characteristics and the survival benefit of kidney transplantation. JAMA 2005; 294: 2726.
7. Palmer A, Taube D, Welsh K, et al. Removal of anti-HLA antibodies by extracorporeal immunoadsorption to enable renal transplantation. Lancet 1989; 1: 10.
8. Nelson PW, Helling TS, Pierce GE, et al. Successful transplantation of blood group A2 kidneys in to non-A recipients. Transplantation 1988; 45: 316.
9. Johnson R, Allen JE, Fuggle SV, et al. UK Transplant NHSBT. Early experience of paired living donation in the United Kingdom. Transplantation 2008; 86: 1672.
10. Toma H, Tanabe K, Tokumoto K. Long term outcome of ABOincompatible renal transplantation. Urol Clin North Am 2001; 28: 769.
11. Tobian AA, Shirey RS, Montgomery RA, et al. The critical role of plasmapheresis in ABO-incompatible renal transplantation. Transfusion 2008; 48: 2453.
12. Winters JL, Gloor JM, Pireda AA, et al. Plasma exchange conditioning for ABO-incompatible renal transplantation. J Clin Apheresis 2004; 19: 79.
13. Cohney SJ, Walker RG, Haeusler MN, et al. Blood group incompatibility in kidney transplantation: Definitely time to re-examine! Med J Aust 2007; 187: 306.
14. Tyden G. The European experience. Transplantation 2007; 84: S2.
15. Galliford J, Charif R, Chan KK, et al. ABO incompatible living renal transplantation with a steroid sparing protocol. Transplantation 2008; 86: 901.
16. Montgomery RA, Locke JE, King KE, et al. ABO Incompatible renal transplantation: A paradigm ready for broad implementation. Transplantation 2009; 87: 1246.
17. Flint SM, Walker RG, Hogan C, et al. Successful ABO-incompatible kidney transplantation with antibody removal and standard immunosuppression. Am J Transpl 2011; 11: 1016.
18. Thibaudin D, Alamartine E, Mariat C, et al. Long-term kinetics of Tlymphocyte subsets in kidney transplant recipients: Influence of anti-T cell antibodies and association with post transplant malignancies. Transplantation 2005; 80: 1514.
19. Sollinger H, Kaplan B, Pescovitz MD, et al. Basiliximab versus antithymocyte globulin for prevention of acute renal allograft rejection. Transplantation 2001; 72: 1915.
20. Onrust SV, Lamb HM, Balfour JA. Rituximab. Drugs 1999; 58: 78.
21. Habicht A, Broker V, Blume C, et al. Increase in infectious complications in ABO incompatible kidney transplant. Nephrol Dial Transplant [Epub ahead of print; doi: 10.1093/ndt/gfr215].
22. Scarsi M, Bossini N, Malacarne F, et al. The number of circulating recent thymic emigrants is severely reduced 1 year after a single dose of alemtuzumab in renal transplant recipients. Transpl Int 2010; 23: 786.
23. Kaplan AA. A simple and accurate method for prescribing plasma exchange. ASAIO Trans 1990; 36: M597.
24. Makidono R. Antigenicity of erythrocytes as analyzed in terms of their cross-reactivity. Microbiol Immunol 1979; 23: 791.
25. Sivakumaran P, Vo AA, Villicana R, et al. Therapeutic plasma exchange for desensitization prior to transplantation in ABO incompatible renal allografts. J Clin Apher 2009; 24: 155.
26. Rydberg L, Bengtsson A, Samuelson O, et al. In vitro assessment of a new ABO immunosorbent with synthetic carbohydrates attached to sepharose. Transpl Int 2005; 17: 666.
27. Cohney SJ, Hogan C, Haeusler M, et al. Variability of anti-blood group titres according to methodology and clinical relevance in ABO-incompatible renal transplantation. Am J Trans 2007; 7: S2 [A42].
28. Kumlien G, Wilpert J, Safwenberg J, et al. Comparing the tube and gel techniques for ABO antibody titration as performed in three European centres. Transplantation 2007; 84(12 Suppl): S17.
29. Genberg H, Kumlien G, Wennberg L, et al. The efficacy of antigenspecific immunoadsorption and rebound of anti-A/B antibodies in ABO-incompatible kidney transplantation. Nephrol Dial Transplant 2011;26:2394-2400.